Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hagay, C.
Right arrow Articles by Pallud, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hagay, C.
Right arrow Articles by Pallud, C. M.

Radiology, Vol 200, 631-638, Copyright © 1996 by Radiological Society of North America

ARTICLES

Contrast-enhanced CT: value for diagnosing local breast cancer recurrence after conservative treatment

C Hagay, PJ Cherel, CE de Maulmont, MM Plantet, R Gilles, JL Floiras, JR Garbay and CM Pallud
Department of Radiology, Centre Rene-Huguenin, Saint-Cloud, France.

PURPOSE: To assess contrast material-enhanced computed tomography (CT) of breast for diagnosing local recurrence after conservative therapy. MATERIALS AND METHODS: In 111 patients, 118 lesions were evaluated with unenhanced and enhanced CT. Criterion for cancer recurrence was detection of a lesion with an enhancement of 45 HU or more. RESULTS: One group comprised 52 lesions with pathologic diagnoses, obtained within 1 month of CT, of malignancy in 43 and benignancy in nine. Scans were positive in 40 of 43 recurrences and negative in six of nine benign lesions. Seventeen recurrent lesions were nonpalpable, and contrast-enhanced CT results were true-positive in 15 of these. A second group comprised 66 lesions with a mean follow-up of the treated breast of 28 months after CT. In 56 lesions, the scans were negative, with no recurrence in 55; local recurrence was proved with a 14-month delayed surgical biopsy in one. In 10 lesions, scans were positive, with a delayed diagnosis of recurrence 5 and 6 months after CT in two and no evidence of recurrence in eight (false-positive results). The sensitivity of breast CT for both groups was 91% (42 of 46 lesions) with a specificity of 85% (61 of 72 lesions). CONCLUSION: Contrast- enhanced CT is sensitive in the diagnosis of local recurrence of breast cancer, even in nonpalpable lesions, and may be a useful tool in patients with equivocal clinical and/or mammographic findings during follow-up after conservative therapy.


This article has been cited by other articles:


Home page
 Am. J. Roentgenol.Home page
D. K. Kang, E. J. Kim, H. S. Kim, J. S. Sun, and Y. S. Jung
Correlation of Whole-Breast Vascularity with Ipsilateral Breast Cancers Using Contrast-Enhanced MDCT
Am. J. Roentgenol., February 1, 2008; 190(2): 496 - 504.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
C. Dromain, C. Balleyguier, S. Muller, M.-C. Mathieu, F. Rochard, P. Opolon, and R. Sigal
Evaluation of tumor angiogenesis of breast carcinoma using contrast-enhanced digital mammography.
Am. J. Roentgenol., November 1, 2006; 187(5): W528 - W537.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
S. J. Swensen
Functional CT: Lung Nodule Evaluation
RadioGraphics, July 1, 2000; 20(4): 1178 - 1181.
[Full Text] [PDF]

Home page
 RadiologyHome page
S. J. Swensen, R. W. Viggiano, D. E. Midthun, N. L. Müller, A. Sherrick, K. Yamashita, D. P. Naidich, E. F. Patz, T. E. Hartman, J. R. Muhm, et al.
Lung Nodule Enhancement at CT: Multicenter Study1
Radiology, January 1, 2000; 214(1): 73 - 80.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 1996 by the Radiological Society of North America.